Table 2.
Integrated approaches between pre-clinical models and humans that provide biological plausibility in assessment of non-fatal developmental disorders.
Brain Assessment | Human | Preclinical Model |
---|---|---|
Behavior | Yes | Yes (Fit to human) |
Neuroanatomy | Neuroimaging Autopsy (rare) |
Neuroimaging Microscopy |
Electrophysiology | EEG, ERP | invasive in vivo and ex vivo recording |
Metabolism | Magnetic Resonance Spectroscopy (MRS) | MRS Direct biochemical assay, including metabolomics of tissue/CSF |
Regulation | Autopsy (rare) CSF analysis (unusual) |
Tissue/CSF gene expression and proteomics |